Injection device maker Milestone Scientific (NYSE:MLSS) topped expectations on Wall Street today with its second quarter results.
The Livingston, N.J.-based company posted a net loss of -$1.5 million on sales of $2.5 million for the 3 months ended June 30, for bottom-line growth of 6.8% on sales growth of 4.2% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Milestone Scientific logs Q2 beat appeared first on MassDevice.
from MassDevice http://ift.tt/2i1lVsQ
Cap comentari:
Publica un comentari a l'entrada